SOX15 Transcriptionally Decreases the Level of MMP2 and Inhibits Vasculogenic Mimicry to Slow Down the Progression of Ovarian Cancer

  • 0Department of Physical Diagnosis, The Second Hospital of Heilongjiang Province, Harbin, Heilongjiang, China.

|

|

Summary

This summary is machine-generated.

Sex-determining region Y-box 15 (SOX15) suppresses ovarian cancer progression by inhibiting vascular mimicry. SOX15 directly represses matrix metalloproteinase-2 (MMP2) expression, offering a new therapeutic target.

Area Of Science

  • Oncology
  • Molecular Biology
  • Cancer Research

Background

  • Vascular mimicry (VM) promotes tumor growth and invasion in ovarian cancer.
  • Sex-determining region Y-box 15 (SOX15) is known to suppress tumor growth, but its role in ovarian cancer is unclear.

Purpose Of The Study

  • To investigate the function of SOX15 in ovarian cancer cell proliferation, invasion, and vascular mimicry.
  • To elucidate the underlying molecular mechanisms of SOX15 action in ovarian cancer.

Main Methods

  • Utilized SKOV-3 and ES2 ovarian cancer cell lines and xenograft mouse models.
  • Assessed cell proliferation, migration, and invasion.
  • Measured VE-cadherin, VEGFA, Ki67, and MMP2 expression.
  • Performed dual-luciferase reporter and ChIP-PCR assays to determine SOX15's mechanism of action.

Main Results

  • SOX15 overexpression inhibited proliferation, migration, and invasion in ovarian cancer cells.
  • SOX15 reduced VM formation by downregulating VE-cadherin and VEGFA.
  • SOX15 knockdown increased tumor growth and VM formation in vivo.
  • SOX15 directly repressed MMP2 promoter activity and expression.

Conclusions

  • SOX15 acts as a tumor suppressor in ovarian cancer by transcriptionally repressing MMP2.
  • Inhibiting VM formation through the SOX15/MMP2 axis presents a potential therapeutic strategy for ovarian cancer.